| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND A (ACC) USD | RENT. ABSOLUTA. | 11,519155 | 30/09/2026 | 10,04% | · | ND |
| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND I (ACC) EUR | RENT. ABSOLUTA. | 11,480000 | 30/09/2026 | 10,92% | · | ND |
| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND I (ACC) USD | RENT. ABSOLUTA. | 11,906649 | 30/09/2026 | 10,60% | · | ND |
| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND I-H1 (ACC) EUR | RENT. ABSOLUTA. | 12,290000 | 30/09/2026 | 5,49% | · | ND |
| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND P2 (ACC) USD | RENT. ABSOLUTA. | 12,100396 | 30/09/2026 | 10,82% | · | ND |
| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND P2-H1 (ACC) EUR | RENT. ABSOLUTA. | 12,490000 | 30/09/2026 | 5,76% | · | ND |
| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND W (ACC) USD | RENT. ABSOLUTA. | 11,158080 | 30/09/2026 | 10,45% | · | ND |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) CHF-H1 | RVI BIOTECNOLOGÍA | 24,994725 | 30/09/2026 | 5,96% | 80,89% | **** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 18,460000 | 30/09/2026 | 9,82% | 90,51% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 4,862226 | 30/09/2026 | 15,60% | 89,02% | ***** |
